Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study User HighYield, in the Chronic Lymphocytic Leukemia (CLL) subreddit, 07 Oct 2020